Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Ann Rheum Dis

Retrieve available abstracts of 194 articles:
HTML format
Text format



Single Articles


    April 2019
  1. VAN MULLIGEN E, de Jong PHP, Kuijper TM, van der Ven M, et al
    Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
    Ann Rheum Dis. 2019 Apr 6. pii: annrheumdis-2018-214970.
    PubMed     Text format     Abstract available


  2. GUO J, Zhang T, Cao H, Li X, et al
    Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population.
    Ann Rheum Dis. 2019 Apr 1. pii: annrheumdis-2018-214725.
    PubMed     Text format     Abstract available


    March 2019
  3. PARK JK, Choi Y, Winthrop KL, Song YW, et al
    Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
    Ann Rheum Dis. 2019 Mar 23. pii: annrheumdis-2019-215187.
    PubMed     Text format    


  4. VISVANATHAN S, Daniluk S, Ptaszynski R, Muller-Ladner U, et al
    Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker parameters in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
    Ann Rheum Dis. 2019 Mar 22. pii: annrheumdis-2018-214729.
    PubMed     Text format     Abstract available



  5. Correction: Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.
    Ann Rheum Dis. 2019 Mar 18. pii: annrheumdis-2015-208093.
    PubMed     Text format    


  6. HUMBY F, Lewis M, Ramamoorthi N, Hackney JA, et al
    Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Ann Rheum Dis. 2019 Mar 16. pii: annrheumdis-2018-214539.
    PubMed     Text format     Abstract available


  7. FENT G, Mankia K, Erhayiem B, Hunt L, et al
    First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.
    Ann Rheum Dis. 2019 Mar 9. pii: annrheumdis-2018-214975.
    PubMed     Text format    


  8. COMBE B, Balsa A, Sarzi-Puttini P, Tony HP, et al
    Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.
    Ann Rheum Dis. 2019 Mar 6. pii: annrheumdis-2018-214261.
    PubMed     Text format    


    February 2019
  9. POPPELAARS PB, van Tuyl LHD, Boers M
    Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.
    Ann Rheum Dis. 2019 Feb 26. pii: annrheumdis-2018-214618.
    PubMed     Text format     Abstract available


  10. WESTERLIND H, Holmqvist M, Ljung L, Frisell T, et al
    Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
    Ann Rheum Dis. 2019 Feb 20. pii: annrheumdis-2018-214828.
    PubMed     Text format     Abstract available


  11. ALPIZAR-RODRIGUEZ D, Lesker TR, Gronow A, Gilbert B, et al
    Prevotella copri in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2018-214514.
    PubMed     Text format     Abstract available


  12. CUTOLO M, Soldano S, Paolino S
    Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis.
    Ann Rheum Dis. 2019 Feb 1. pii: annrheumdis-2019-215063.
    PubMed     Text format    


    January 2019
  13. PAWAR A, Desai RJ, Solomon DH, Santiago Ortiz AJ, et al
    Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
    Ann Rheum Dis. 2019 Jan 24. pii: annrheumdis-2018-214367.
    PubMed     Text format     Abstract available


  14. NORGARD BM, Larsen MD, Friedman S, Knudsen T, et al
    Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
    Ann Rheum Dis. 2019 Jan 12. pii: annrheumdis-2018-214619.
    PubMed     Text format     Abstract available


  15. GRON KL, Arkema EV, Glintborg B, Mehnert F, et al
    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
    Ann Rheum Dis. 2019 Jan 5. pii: annrheumdis-2018-214326.
    PubMed     Text format     Abstract available


  16. BURGGRAAF B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, et al
    Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2019 Jan 4. pii: annrheumdis-2018-214075.
    PubMed     Text format     Abstract available


  17. CHEN YM, Huang WN, Liao TL, Chen JP, et al
    Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
    Ann Rheum Dis. 2019 Jan 3. pii: annrheumdis-2018-214400.
    PubMed     Text format    


    December 2018
  18. OKADA Y, Eyre S, Suzuki A, Kochi Y, et al
    Genetics of rheumatoid arthritis: 2018 status.
    Ann Rheum Dis. 2018 Dec 8. pii: annrheumdis-2018-213678.
    PubMed     Text format     Abstract available


  19. GERLAG DM, Safy M, Maijer KI, Tang MW, et al
    Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.
    Ann Rheum Dis. 2018 Dec 1. pii: annrheumdis-2017-212763.
    PubMed     Text format     Abstract available


    October 2018
  20. BERGSTRA SA, Winchow LL, Murphy E, Chopra A, et al
    How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.
    Ann Rheum Dis. 2018 Oct 16. pii: annrheumdis-2018-213731.
    PubMed     Text format     Abstract available


  21. SINGH JA
    Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?
    Ann Rheum Dis. 2018 Oct 9. pii: annrheumdis-2018-213694.
    PubMed     Text format    


  22. ZHU H, Wu LF, Mo XB, Lu X, et al
    Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213970.
    PubMed     Text format     Abstract available


  23. PARK JK, Lee YJ, Bitoun S, Winthrop KL, et al
    Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-214025.
    PubMed     Text format    


  24. MARTINEZ-PRAT L, Lucia D, Ibarra C, Mahler M, et al
    Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Oct 8. pii: annrheumdis-2018-213818.
    PubMed     Text format    


    September 2018
  25. DIEKHOFF T, Ulas ST, Poddubnyy D, Schneider U, et al
    Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 29. pii: annrheumdis-2018-213904.
    PubMed     Text format     Abstract available


  26. TSUJI H, Ikari K, Ohmura K, Yano K, et al
    Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Sep 19. pii: annrheumdis-2018-214022.
    PubMed     Text format    


  27. TAKEUCHI T, Genovese MC, Haraoui B, Li Z, et al
    Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213271.
    PubMed     Text format     Abstract available


  28. ROODENRIJS NMT, de Hair MJH, van der Goes MC, Jacobs JWG, et al
    Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
    Ann Rheum Dis. 2018 Sep 7. pii: annrheumdis-2018-213687.
    PubMed     Text format     Abstract available


    August 2018
  29. TEITSMA XM, Jacobs JWG, de Jong PHP, Hazes JMW, et al
    Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 29. pii: annrheumdis-2018-213767.
    PubMed     Text format    


  30. RIVELLESE F, Mauro D, Nerviani A, Pagani S, et al
    Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-213418.
    PubMed     Text format     Abstract available


  31. FERREIRA RJO, Ndosi M, de Wit M, Santos EJF, et al
    Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Aug 20. pii: annrheumdis-2018-214199.
    PubMed     Text format    


  32. VAN DELFT MAM, van der Woude D, Toes REM, Trouw LA, et al
    Secretory form of rheumatoid arthritis-associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces.
    Ann Rheum Dis. 2018 Aug 14. pii: annrheumdis-2018-213724.
    PubMed     Text format    


  33. LANDEWE RBM
    Response to: 'Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewe.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214172.
    PubMed     Text format    


  34. VAN DER HELM-VAN MIL A
    Early identification of rheumatoid arthritis: the risk of overtreatment in perspective.
    Ann Rheum Dis. 2018 Aug 10. pii: annrheumdis-2018-214156.
    PubMed     Text format    


  35. SMOLEN JS, van Vollenhoven RF, Florentinus S, Chen S, et al
    Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Ann Rheum Dis. 2018 Aug 3. pii: annrheumdis-2018-213502.
    PubMed     Text format     Abstract available


    July 2018
  36. BUSTAMANTE MF, Oliveira PG, Garcia-Carbonell R, Croft AP, et al
    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 30. pii: annrheumdis-2018-213103.
    PubMed     Text format     Abstract available


  37. JIN S, Chen H, Li Y, Zhong H, et al
    Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
    Ann Rheum Dis. 2018 Jul 25. pii: annrheumdis-2018-213511.
    PubMed     Text format     Abstract available


  38. BITOUN S, Miceli-Richard C, Verstuyft C, Juge PA, et al
    Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
    Ann Rheum Dis. 2018 Jul 20. pii: annrheumdis-2018-213183.
    PubMed     Text format    


  39. JANS L, De Kock I, Herregods N, Verstraete KL, et al
    Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213960.
    PubMed     Text format    


  40. WU H, Zhang G, Huang X, Liang C, et al
    Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?
    Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213892.
    PubMed     Text format    


  41. LEE JY, Kang MJ, Choi JY, Park JS, et al
    Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 11. pii: annrheumdis-2018-213444.
    PubMed     Text format     Abstract available


  42. NEUMANN E, Schwarz MC, Hasseli R, Hulser ML, et al
    Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-212954.
    PubMed     Text format     Abstract available


  43. KEARSLEY-FLEET L, Davies R, De Cock D, Watson KD, et al
    Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Jul 6. pii: annrheumdis-2018-213378.
    PubMed     Text format     Abstract available


  44. DIAZ-GALLO LM, Ramskold D, Shchetynsky K, Folkersen L, et al
    Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 2. pii: annrheumdis-2018-213412.
    PubMed     Text format     Abstract available


    June 2018
  45. PAULSHUS SUNDLISAETER N, Aga AB, Olsen IC, Hammer HB, et al
    Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Ann Rheum Dis. 2018 Jun 22. pii: annrheumdis-2017-212830.
    PubMed     Text format     Abstract available


  46. SOHRABIAN A, Mathsson-Alm L, Hansson M, Knight A, et al
    Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jun 12. pii: annrheumdis-2017-212627.
    PubMed     Text format     Abstract available


  47. FILIPPOU G, Sakellariou G, Scire CA, Carrara G, et al
    The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the
    Ann Rheum Dis. 2018 Jun 9. pii: annrheumdis-2018-213217.
    PubMed     Text format     Abstract available


  48. HILLIQUIN S, Hugues B, Mitrovic S, Gossec L, et al
    Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.
    Ann Rheum Dis. 2018 Jun 8. pii: annrheumdis-2017-212612.
    PubMed     Text format     Abstract available


  49. MICHELSEN B, Uhlig T, Sexton J, van der Heijde D, et al
    Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
    Ann Rheum Dis. 2018 Jun 6. pii: annrheumdis-2018-213286.
    PubMed     Text format     Abstract available


    May 2018
  50. KANEKO Y, Kato M, Tanaka Y, Inoo M, et al
    Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SUR
    Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213416.
    PubMed     Text format     Abstract available


  51. TEITSMA XM, Jacobs JWG, Welsing PMJ, de Jong PHP, et al
    Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
    Ann Rheum Dis. 2018 May 14. pii: annrheumdis-2018-213035.
    PubMed     Text format     Abstract available


  52. LAUPER K, Nordstrom DC, Pavelka K, Hernandez MV, et al
    Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modi
    Ann Rheum Dis. 2018 May 5. pii: annrheumdis-2017-212845.
    PubMed     Text format     Abstract available


  53. HEDSTROM AK, Klareskog L, Alfredsson L
    Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.
    Ann Rheum Dis. 2018 May 3. pii: annrheumdis-2018-212973.
    PubMed     Text format     Abstract available


  54. MUNICIO C, Dominguez-Soto A, Fuentelsaz-Romero S, Lamana A, et al
    Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Ann Rheum Dis. 2018;77:752-759.
    PubMed     Text format     Abstract available


  55. FRISELL T, Baecklund E, Bengtsson K, Di Giuseppe D, et al
    Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
    Ann Rheum Dis. 2018;77:650-657.
    PubMed     Text format     Abstract available


  56. PISETSKY DS
    How the gut inflames the joints.
    Ann Rheum Dis. 2018;77:634-635.
    PubMed     Text format    


  57. WINTHROP KL, Baddley JW
    Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.
    Ann Rheum Dis. 2018;77:631-633.
    PubMed     Text format    


    April 2018
  58. BOER AC, Boeters DM, van der Helm-van Mil AHM
    The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?
    Ann Rheum Dis. 2018 Apr 20. pii: annrheumdis-2018-213143.
    PubMed     Text format     Abstract available


  59. CHEN YM, Liao TL, Chen HH, Chen DY, et al
    Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 19. pii: annrheumdis-2018-213097.
    PubMed     Text format    


  60. SANTOS EJF, Duarte C, Ferreira RJO, Pinto AM, et al
    Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach.
    Ann Rheum Dis. 2018 Apr 6. pii: annrheumdis-2017-212934.
    PubMed     Text format     Abstract available


  61. BONDT A, Hafkenscheid L, Falck D, Kuijper TM, et al
    ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Apr 3. pii: annrheumdis-2018-212946.
    PubMed     Text format     Abstract available


  62. MOSSEL E, Arends S, van Nimwegen JF, Delli K, et al
    Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:556-562.
    PubMed     Text format     Abstract available


  63. DAIEN CI, Tubery A, Cailar GD, Mura T, et al
    Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study.
    Ann Rheum Dis. 2018;77:625-626.
    PubMed     Text format    


  64. MULLEMAN D, Balsa A
    Adalimumab concentration-based tapering strategy: as good as the recommended dosage.
    Ann Rheum Dis. 2018;77:473-475.
    PubMed     Text format    


    March 2018
  65. RUTHERFORD AI, Subesinghe S, Hyrich KL, Galloway JB, et al
    Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatolgy Biologics Register for Rheumatoid Arthritis.
    Ann Rheum Dis. 2018 Mar 28. pii: annrheumdis-2017-212825.
    PubMed     Text format     Abstract available


  66. BUCH MH
    Defining refractory rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 27. pii: annrheumdis-2017-212862.
    PubMed     Text format     Abstract available


  67. PARK JK, Lee YJ, Shin K, Ha YJ, et al
    Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2018 Mar 23. pii: annrheumdis-2018-213222.
    PubMed     Text format     Abstract available


  68. COHEN SB, Alonso-Ruiz A, Klimiuk PA, Lee EC, et al
    Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212245.
    PubMed     Text format     Abstract available


  69. LEONARD D, Svenungsson E, Dahlqvist J, Alexsson A, et al
    Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 7. pii: annrheumdis-2017-212614.
    PubMed     Text format     Abstract available


  70. GADEHOLT O
    Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 6. pii: annrheumdis-2018-213278.
    PubMed     Text format    


  71. JANS L, De Kock I, Herregods N, Verstraete K, et al
    Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2018-213152.
    PubMed     Text format    


  72. JUST SA, Rostgaard K, Titlestad K, Edgren G, et al
    Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.
    Ann Rheum Dis. 2018 Mar 1. pii: annrheumdis-2017-212844.
    PubMed     Text format    


  73. FISHER BA, Everett CC, Rout J, O'Dwyer JL, et al
    Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
    Ann Rheum Dis. 2018;77:412-416.
    PubMed     Text format     Abstract available


    February 2018
  74. TAYLOR PC, Schiff MH, Wang Q, Jiang Y, et al
    Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.
    Ann Rheum Dis. 2018 Feb 26. pii: annrheumdis-2017-212496.
    PubMed     Text format     Abstract available


  75. STEMMLER F, Simon D, Liphardt AM, Englbrecht M, et al
    Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures.
    Ann Rheum Dis. 2018 Feb 23. pii: annrheumdis-2017-212404.
    PubMed     Text format     Abstract available


  76. LI HZ, Xu XH, Lin N, Lu HD, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2018-213157.
    PubMed     Text format    


  77. DE PABLO P, Romaguera D, Fisk HL, Calder PC, et al
    High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case-control study.
    Ann Rheum Dis. 2018 Feb 7. pii: annrheumdis-2017-212274.
    PubMed     Text format     Abstract available


  78. ZEISBRICH M, Yanes RE, Zhang H, Watanabe R, et al
    Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation.
    Ann Rheum Dis. 2018 Feb 3. pii: annrheumdis-2017-212647.
    PubMed     Text format     Abstract available


    January 2018
  79. VAN HOOVELS L, Jacobs J, Vander Cruyssen B, Van den Bremt S, et al
    Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 23. pii: annrheumdis-2017-212365.
    PubMed     Text format     Abstract available


  80. VAN VOLLENHOVEN RF, Keystone EC, Strand V, Pacheco-Tena C, et al
    Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
    Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478.
    PubMed     Text format     Abstract available


  81. CHEVREAU M, Paclet MH, Romand X, Quesada JL, et al
    Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al.
    Ann Rheum Dis. 2018 Jan 10. pii: annrheumdis-2017-212816.
    PubMed     Text format    


  82. BOER AC, Huizinga TWJ, van der Helm-van Mil AHM
    Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 8. pii: annrheumdis-2017-212867.
    PubMed     Text format    


  83. RADNER H, Chatzidionysiou K, Nikiphorou E, Gossec L, et al
    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 4. pii: annrheumdis-2017-212256.
    PubMed     Text format     Abstract available


  84. AKDEMIR G, Heimans L, Bergstra SA, Goekoop RJ, et al
    Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
    Ann Rheum Dis. 2018;77:111-118.
    PubMed     Text format     Abstract available


  85. SCHONAU V, Vogel K, Englbrecht M, Wacker J, et al
    The value of (18)F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
    Ann Rheum Dis. 2018;77:70-77.
    PubMed     Text format     Abstract available


  86. WANG-RENAULT SF, Boudaoud S, Nocturne G, Roche E, et al
    Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2018;77:133-140.
    PubMed     Text format     Abstract available


    December 2017
  87. CURTIS JR, Xie F, Chen L, Saag KG, et al
    Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Ann Rheum Dis. 2017 Dec 21. pii: annrheumdis-2017-211727.
    PubMed     Text format     Abstract available


  88. MATSUNO H, Tomomitsu M, Hagino A, Shin S, et al
    Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding
    Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172.
    PubMed     Text format     Abstract available


  89. FRAENKEL L, Nowell WB, Michel G, Wiedmeyer C, et al
    Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212407.
    PubMed     Text format     Abstract available


  90. CORDTZ RL, Hawley S, Prieto-Alhambra D, Hojgaard P, et al
    Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.
    Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212424.
    PubMed     Text format     Abstract available


  91. DREYER L, Cordtz RL, Hansen IMJ, Kristensen LE, et al
    Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
    Ann Rheum Dis. 2017 Dec 7. pii: annrheumdis-2017-212086.
    PubMed     Text format     Abstract available


  92. GAUJOUX-VIALA C, Rincheval N, Dougados M, Combe B, et al
    Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Ann Rheum Dis. 2017;76:2054-2060.
    PubMed     Text format     Abstract available


  93. TSUBOI H, Hagiwara S, Asashima H, Takahashi H, et al
    Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome with other sets of criteria in Japanese patients.
    Ann Rheum Dis. 2017;76:1980-1985.
    PubMed     Text format     Abstract available


    November 2017
  94. SMILJANOVIC B, Radzikowska A, Kuca-Warnawin E, Kurowska W, et al
    Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint.
    Ann Rheum Dis. 2017 Nov 30. pii: annrheumdis-2017-211649.
    PubMed     Text format     Abstract available


  95. HENAUX S, Ruyssen-Witrand A, Cantagrel A, Barnetche T, et al
    Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
    Ann Rheum Dis. 2017 Nov 29. pii: annrheumdis-2017-212423.
    PubMed     Text format     Abstract available


  96. WEIJERS JM, Rongen-van Dartel SAA, Hoevenaars DMGMF, Rubens M, et al
    Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care.
    Ann Rheum Dis. 2017 Nov 22. pii: annrheumdis-2017-212392.
    PubMed     Text format     Abstract available


  97. MO WX, Yin SS, Chen H, Zhang X, et al
    Amino-bisphosphonates, gammadeltaT cells, and their roles in Rheumatoid Arthritis.
    Ann Rheum Dis. 2017 Nov 17. pii: annrheumdis-2017-212569.
    PubMed     Text format    


  98. KAVANAUGH A, van Vollenhoven R, Fleischmann RM, Emery P, et al
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871.
    PubMed     Text format     Abstract available


  99. L'AMI MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
    Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602.
    PubMed     Text format    


  100. GOSSEC L, Chauvin P, Saraux A, Hudry C, et al
    Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.
    Ann Rheum Dis. 2017 Nov 4. pii: annrheumdis-2017-212000.
    PubMed     Text format     Abstract available


  101. CORDTZ RL, Zobbe K, Hojgaard P, Kristensen LE, et al
    Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
    Ann Rheum Dis. 2017 Nov 2. pii: annrheumdis-2017-212339.
    PubMed     Text format     Abstract available


  102. MOSSEL E, Delli K, van Nimwegen JF, Stel AJ, et al
    Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1883-1889.
    PubMed     Text format     Abstract available


  103. DEN BROEDER AA, van den Bemt BJF
    Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'.
    Ann Rheum Dis. 2017 Nov 1. pii: annrheumdis-2017-212579.
    PubMed     Text format    


    October 2017
  104. ROSSINI M, Adami G, Viapiana O, Idolazzi L, et al
    Rheumatoid arthritis, gammadelta T cells and bisphosphonates.
    Ann Rheum Dis. 2017 Oct 26. pii: annrheumdis-2017-212510.
    PubMed     Text format    


  105. SHI J, Darrah E, Sims GP, Mustelin T, et al
    Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211489.
    PubMed     Text format     Abstract available


  106. RONNELID J, Hansson M, Mathsson-Alm L, Cornillet M, et al
    Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
    Ann Rheum Dis. 2017 Oct 25. pii: annrheumdis-2017-211782.
    PubMed     Text format     Abstract available


  107. SMOLEN JS, Choe JY, Prodanovic N, Niebrzydowski J, et al
    Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition st
    Ann Rheum Dis. 2017 Oct 17. pii: annrheumdis-2017-211741.
    PubMed     Text format     Abstract available


  108. ERIKSSON K, Nise L, Alfredsson L, Catrina AI, et al
    Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Oct 6. pii: annrheumdis-2017-212091.
    PubMed     Text format    


  109. BRAUNER S, Folkersen L, Kvarnstrom M, Meisgen S, et al
    H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Ann Rheum Dis. 2017;76:1755-1763.
    PubMed     Text format     Abstract available


  110. HAACKE EA, van der Vegt B, Vissink A, Spijkervet FKL, et al
    Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren's syndrome are not predictive for parotid MALT lymphoma development.
    Ann Rheum Dis. 2017;76:1781-1784.
    PubMed     Text format     Abstract available


  111. BURGERS LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, et al
    Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Ann Rheum Dis. 2017;76:1751-1754.
    PubMed     Text format     Abstract available


    September 2017
  112. HOLMQVIST M, Ljung L, Askling J
    Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
    Ann Rheum Dis. 2017 Sep 26. pii: annrheumdis-2017-212131.
    PubMed     Text format     Abstract available


  113. REMPENAULT C, Combe B, Barnetche T, Gaujoux-Viala C, et al
    Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017 Sep 25. pii: annrheumdis-2017-211836.
    PubMed     Text format     Abstract available


  114. MORITA T, Fujimoto K, Shima Y, Ogata A, et al
    Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-212366.
    PubMed     Text format    


  115. L'AMI MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, et al
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
    Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211781.
    PubMed     Text format     Abstract available


  116. ROBERTSON J, Porter D, Sattar N, Packard CJ, et al
    Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-211708.
    PubMed     Text format     Abstract available


  117. ZENG P, Chen Z, Klareskog L, Alfredsson L, et al
    Amount of smoking, duration of smoking cessation and their interaction with silica exposure in the risk of rheumatoid arthritis among males: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.
    Ann Rheum Dis. 2017 Sep 15. pii: annrheumdis-2017-212145.
    PubMed     Text format    


  118. CROWSON CS, Rollefstad S, Ikdahl E, Kitas GD, et al
    Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 6. pii: annrheumdis-2017-211735.
    PubMed     Text format     Abstract available


  119. MO WX, Yin SS, Chen H, Zhou C, et al
    Chemotaxis of Vdelta2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2016-211069.
    PubMed     Text format     Abstract available


  120. BREBAN M, Tap J, Leboime A, Said-Nahal R, et al
    Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Ann Rheum Dis. 2017;76:1614-1622.
    PubMed     Text format     Abstract available


    August 2017
  121. TAKEUCHI T, Thorne C, Karpouzas G, Sheng S, et al
    Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
    Ann Rheum Dis. 2017 Aug 30. pii: annrheumdis-2017-211328.
    PubMed     Text format     Abstract available


  122. FILER A, Ward LSC, Kemble S, Davies CS, et al
    Identification of a transitional fibroblast function in very early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 28. pii: annrheumdis-2017-211286.
    PubMed     Text format     Abstract available


  123. OIWA H
    Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212206.
    PubMed     Text format    


  124. ORYOJI K, Yoshida K, Kashiwado Y, Tanaka K, et al
    Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-211430.
    PubMed     Text format    


  125. OLSEN CM, Green AC
    Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis.
    Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212205.
    PubMed     Text format    


  126. MANTEL A, Holmqvist M, Jernberg T, Wallberg-Jonsson S, et al
    Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 20. pii: annrheumdis-2017-211608.
    PubMed     Text format     Abstract available


  127. MERCER LK, Regierer AC, Mariette X, Dixon WG, et al
    Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
    Ann Rheum Dis. 2017 Aug 19. pii: annrheumdis-2017-211623.
    PubMed     Text format     Abstract available


  128. ORELLANA C, Saevarsdottir S, Klareskog L, Karlson EW, et al
    Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Ann Rheum Dis. 2017 Aug 17. pii: annrheumdis-2017-211620.
    PubMed     Text format     Abstract available


  129. JONSSON MK, Sundlisaeter NP, Nordal HH, Hammer HB, et al
    Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 16. pii: annrheumdis-2017-211695.
    PubMed     Text format     Abstract available


  130. SCALLY SW, Law SC, Ting YT, Heemst JV, et al
    Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2017-211300.
    PubMed     Text format     Abstract available


  131. BRINKMANN GH, Norli ES, Boyesen P, Heijde DVH, et al
    Role of erosions typical of rheumatoid arthritis in the 2010 ACR/EULAR rheumatoid arthritis classification criteria: results from a very early arthritis cohort.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211350.
    PubMed     Text format     Abstract available


  132. KEYSTONE EC, Taylor PC, Tanaka Y, Gaich C, et al
    Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Ann Rheum Dis. 2017 Aug 10. pii: annrheumdis-2017-211259.
    PubMed     Text format     Abstract available


  133. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
    Ann Rheum Dis. 2017 Aug 9. pii: annrheumdis-2017-211591.
    PubMed     Text format     Abstract available


  134. TAK PP, Doorenspleet ME, de Hair MJH, Klarenbeek PL, et al
    Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
    Ann Rheum Dis. 2017 Aug 8. pii: annrheumdis-2017-211351.
    PubMed     Text format     Abstract available


  135. DE JONG AJ, Klein-Wieringa IR, Kwekkeboom JC, Toes REM, et al
    Inflammatory features of infrapatellar fat pad in rheumatoid arthritis versus osteoarthritis reveal mostly qualitative differences.
    Ann Rheum Dis. 2017 Aug 5. pii: annrheumdis-2017-211673.
    PubMed     Text format    


  136. CAPORALI R, Smolen JS
    Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management.
    Ann Rheum Dis. 2017 Aug 2. pii: annrheumdis-2017-211458.
    PubMed     Text format     Abstract available


  137. BAKER KF, Isaacs JD
    Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
    Ann Rheum Dis. 2017 Aug 1. pii: annrheumdis-2017-211555.
    PubMed     Text format     Abstract available


  138. TASAKI S, Suzuki K, Nishikawa A, Kassai Y, et al
    Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1458-1466.
    PubMed     Text format     Abstract available


  139. LISNEY AR, Szelinski F, Reiter K, Burmester GR, et al
    High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Ann Rheum Dis. 2017;76:1476-1480.
    PubMed     Text format     Abstract available


  140. GLINTBORG B, Sorensen IJ, Loft AG, Lindegaard H, et al
    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
    Ann Rheum Dis. 2017;76:1426-1431.
    PubMed     Text format     Abstract available


  141. DEKKERS JS, Verheul MK, Stoop JN, Liu B, et al
    Breach of autoreactive B cell tolerance by post-translationally modified proteins.
    Ann Rheum Dis. 2017;76:1449-1457.
    PubMed     Text format     Abstract available


  142. SCHIEIR O, Tosevski C, Glazier RH, Hogg-Johnson S, et al
    Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
    Ann Rheum Dis. 2017;76:1396-1404.
    PubMed     Text format     Abstract available


  143. MORADI-LAKEH M, Forouzanfar MH, Vollset SE, El Bcheraoui C, et al
    Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.
    Ann Rheum Dis. 2017;76:1365-1373.
    PubMed     Text format     Abstract available


    July 2017
  144. MICHELSEN B, Kristianslund EK, Sexton J, Hammer HB, et al
    Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
    Ann Rheum Dis. 2017 Jul 21. pii: annrheumdis-2017-211284.
    PubMed     Text format     Abstract available


  145. HOLMQVIST M, Ljung L, Askling J
    Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Ann Rheum Dis. 2017 Jul 14. pii: annrheumdis-2016-211066.
    PubMed     Text format     Abstract available


  146. VAN SCHIE KA, Ooijevaar-De Heer P, Kruithof S, Plasencia C, et al
    Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.
    Ann Rheum Dis. 2017;76:1285-1288.
    PubMed     Text format     Abstract available


  147. BOUTET MA, Najm A, Bart G, Brion R, et al
    IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
    Ann Rheum Dis. 2017;76:1304-1312.
    PubMed     Text format     Abstract available


  148. VAN ZANTEN A, Arends S, Roozendaal C, Limburg PC, et al
    Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.
    Ann Rheum Dis. 2017;76:1184-1190.
    PubMed     Text format     Abstract available


  149. FISHER BA, Jonsson R, Daniels T, Bombardieri M, et al
    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:1161-1168.
    PubMed     Text format     Abstract available


    June 2017
  150. CHEN YM, Huang WN, Wu YD, Lin CT, et al
    Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study.
    Ann Rheum Dis. 2017 Jun 29. pii: annrheumdis-2017-211322.
    PubMed     Text format    


  151. RUBBERT-ROTH A, Jacobs JWG, Bijlsma JWJ, Welsing PMJ, et al
    A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement.
    Ann Rheum Dis. 2017 Jun 23. pii: annrheumdis-2017-211485.
    PubMed     Text format    


  152. SMOLEN JS, Cohen SB, Tony HP, Scheinberg M, et al
    A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 21. pii: annrheumdis-2017-211281.
    PubMed     Text format     Abstract available


  153. HYLDGAARD C, Hilberg O, Pedersen AB, Ulrichsen SP, et al
    A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211138.
    PubMed     Text format     Abstract available


  154. GLINATSI D, Baker JF, Hetland ML, Horslev-Petersen K, et al
    Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled tr
    Ann Rheum Dis. 2017 Jun 13. pii: annrheumdis-2017-211315.
    PubMed     Text format     Abstract available


  155. GEORGE MD, Ostergaard M, Conaghan PG, Emery P, et al
    Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211569.
    PubMed     Text format     Abstract available


  156. ARTS EE, Fransen J, Den Broeder AA, van Riel PLCM, et al
    Low disease activity (DAS28</=3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2016-210997.
    PubMed     Text format     Abstract available


  157. BOUMAN CA, Herwaarden NV, van den Hoogen FH, Fransen J, et al
    Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial.
    Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211169.
    PubMed     Text format     Abstract available


  158. BELKHIR R, Burel SL, Dunogeant L, Marabelle A, et al
    Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Ann Rheum Dis. 2017 Jun 9. pii: annrheumdis-2017-211216.
    PubMed     Text format     Abstract available


  159. HUMPHREYS JH, Costello R, Verstappen SM, Dixon WG, et al
    Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211670.
    PubMed     Text format    


  160. KREMER JM, Weinblatt ME
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211632.
    PubMed     Text format    


  161. THOMSEN T, Aadahl M, Beyer N, Hetland ML, et al
    The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210953.
    PubMed     Text format     Abstract available


  162. COHEN S, Genovese MC, Choy E, Perez-Ruiz F, et al
    Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210459.
    PubMed     Text format     Abstract available


  163. BRITO-ZERON P, Acar-Denizli N, Zeher M, Rasmussen A, et al
    Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium.
    Ann Rheum Dis. 2017;76:1042-1050.
    PubMed     Text format     Abstract available


    May 2017
  164. MEISSNER Y, Richter A, Manger B, Tony HP, et al
    Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
    Ann Rheum Dis. 2017 May 8. pii: annrheumdis-2017-211209.
    PubMed     Text format     Abstract available


  165. SMOLEN JS, Landewe RBM, van der Heijde D
    Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra et al.
    Ann Rheum Dis. 2017 May 6. pii: annrheumdis-2017-211455.
    PubMed     Text format    


  166. BUTTGEREIT F, Bijlsma JW
    Glucocorticoids in rheumatoid arthritis: the picture is shaping up.
    Ann Rheum Dis. 2017 May 4. pii: annrheumdis-2017-211187.
    PubMed     Text format    


  167. PARK JK, Lee MA, Lee EY, Song YW, et al
    Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Ann Rheum Dis. 2017 May 3. pii: annrheumdis-2017-211128.
    PubMed     Text format     Abstract available


  168. OGDIE A, Harter L, Shin D, Baker J, et al
    The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
    Ann Rheum Dis. 2017;76:882-885.
    PubMed     Text format     Abstract available


    April 2017
  169. SAFY M, Jacobs J, IJff ND, Bijlsma J, et al
    Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2016-210647.
    PubMed     Text format     Abstract available


  170. PIRILA L, Sokka T, Kauppi MJ, Rantalaiho VM, et al
    Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.
    Ann Rheum Dis. 2017 Apr 27. pii: annrheumdis-2017-211505.
    PubMed     Text format    


  171. CRUZ GI, Shao X, Quach H, Ho KA, et al
    Increased risk of rheumatoid arthritis among mothers with children who carry DRB1 risk-associated alleles.
    Ann Rheum Dis. 2017 Apr 8. doi: 10.1136/annrheumdis-2016-210662.
    PubMed     Text format     Abstract available


  172. BURMESTER GR, Rigby WF, van Vollenhoven RF, Kay J, et al
    Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210561.
    PubMed     Text format     Abstract available


    March 2017
  173. CHATZIDIONYSIOU K, Emamikia S, Nam J, Ramiro S, et al
    Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711.
    PubMed     Text format     Abstract available


  174. MISRA DP, Agarwal V, Sharma A, Wakhlu A, et al
    2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
    Ann Rheum Dis. 2017 Mar 27. pii: annrheumdis-2017-211446.
    PubMed     Text format    


  175. HUMPHREYS JH, Warner A, Costello R, Lunt M, et al
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210629.
    PubMed     Text format     Abstract available


  176. MANIVEL VA, Mullazehi M, Padyukov L, Westerlind H, et al
    Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210873.
    PubMed     Text format     Abstract available


  177. CHARRAS A, Konsta OD, Le Dantec C, Bagacean C, et al
    Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjogren's syndrome.
    Ann Rheum Dis. 2017;76:625-628.
    PubMed     Text format     Abstract available


  178. ROSS EA, Naylor AJ, O'Neil JD, Crowley T, et al
    Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
    Ann Rheum Dis. 2017;76:612-619.
    PubMed     Text format     Abstract available


  179. THORARENSEN SM, Lu N, Ogdie A, Gelfand JM, et al
    Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
    Ann Rheum Dis. 2017;76:521-525.
    PubMed     Text format     Abstract available


    February 2017
  180. MAEHARA T, Mattoo H, Ohta M, Mahajan VS, et al
    Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
    Ann Rheum Dis. 2017;76:377-385.
    PubMed     Text format     Abstract available


  181. ROSSETTI M, Spreafico R, Consolaro A, Leong JY, et al
    TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.
    Ann Rheum Dis. 2017;76:435-441.
    PubMed     Text format     Abstract available


  182. NORDBERG LB, Lillegraven S, Lie E, Aga AB, et al
    Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR/EULAR criteria.
    Ann Rheum Dis. 2017;76:341-345.
    PubMed     Text format     Abstract available


    January 2017
  183. ALAWI KM, Russell FA, Aubdool AA, Srivastava S, et al
    Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
    Ann Rheum Dis. 2017;76:252-260.
    PubMed     Text format     Abstract available


  184. BELL GM, Anderson AE, Diboll J, Reece R, et al
    Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
    Ann Rheum Dis. 2017;76:227-234.
    PubMed     Text format     Abstract available


  185. DOUGADOS M, van der Heijde D, Chen YC, Greenwald M, et al
    Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
    Ann Rheum Dis. 2017;76:88-95.
    PubMed     Text format     Abstract available


  186. SHIBOSKI CH, Shiboski SC, Seror R, Criswell LA, et al
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Ann Rheum Dis. 2017;76:9-16.
    PubMed     Text format     Abstract available


  187. CAPPELLI LC, Gutierrez AK, Baer AN, Albayda J, et al
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Ann Rheum Dis. 2017;76:43-50.
    PubMed     Text format     Abstract available


  188. HENSVOLD AH, Frisell T, Magnusson PK, Holmdahl R, et al
    How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Ann Rheum Dis. 2017;76:119-125.
    PubMed     Text format     Abstract available


  189. CHOE JY, Prodanovic N, Niebrzydowski J, Staykov I, et al
    A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:58-64.
    PubMed     Text format     Abstract available


  190. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:51-57.
    PubMed     Text format     Abstract available


    October 2016
  191. HUNT L, Hensor EM, Nam J, Burska AN, et al
    T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.
    Ann Rheum Dis. 2016;75:1884-9.
    PubMed     Text format     Abstract available


  192. VAN HEEMST J, Hensvold AH, Jiang X, van Steenbergen H, et al
    Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    Ann Rheum Dis. 2016;75:1891-8.
    PubMed     Text format     Abstract available


  193. CORSIERO E, Bombardieri M, Carlotti E, Pratesi F, et al
    Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
    Ann Rheum Dis. 2016;75:1866-75.
    PubMed     Text format     Abstract available


  194. VAN STEENBERGEN HW, Mangnus L, Reijnierse M, Huizinga TW, et al
    Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.
    Ann Rheum Dis. 2016;75:1824-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: